LH gains from specialty testing growth, acquisitions and AI initiatives, but currency swings and macro pressures remain risks.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp (LH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Labcorp's shares rise after Q1 beats on earnings and revenues, with growth across segments and a higher 2026 outlook signaling continued momentum.
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Labcorp Holdings (LH) came out with quarterly earnings of $4.25 per share, beating the Zacks Consensus Estimate of $4.09 per share. This compares to earnings of $3.84 per share a year ago.
Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results above expectations as demand for ​diagnostic testing remained steady.
Beyond analysts' top-and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).